Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension

NCT00494533 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

45

Enrollment

INDUSTRY

Sponsor class

Stopped Safety issues related to outpatient intravenous infusion in India

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Remodulin (treprostinil sodium)

Sponsor

United Therapeutics

Collaborators

[object Object]